Sort
64,565 grants matching “drug discovery”
Pharmacogenetics of Membrane Transporters
$2,881,004Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2006 · GM
Clinical and Translational Science Award
$2,880,704Harry Shamoon · Albert Einstein College Of Medicine, Inc · UL1 · FY2018 · TR
Targeting Transcription and Splicing in Cancer
$2,880,000Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Targeting Transcription and Splicing in Cancer
$2,880,000Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
$2,879,931Dennis William Dickson · Mayo Clinic Jacksonville · U54 · FY2022 · NS
SPORE IN PROSTATE CANCER
$2,878,971Johns Hopkins University · P50 · FY2000 · CA
Pharmacogenetics of Membrane Transporters
$2,875,269Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2007 · GM
NCATS ASPIRE REDUCTION-TO-PRACTICE CHALLENGE
$2,875,000 · N01 · FY2020 · TR
Phase 3 trial of inosine for Parkinson's disease CCC
$2,874,019Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2018 · NS
Development of Complement Modulating Therapeutics for AMD
$2,873,998Gregory S Hageman · University Of Iowa · R24 · FY2008 · EY
Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets
$2,872,722Yu Chen · University Of South Florida · R01 · FY2025 · AI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
$2,871,778Dennis William Dickson · Mayo Clinic Jacksonville · U54 · FY2023 · NS
Autonomic Pharmacodynamic Pharmacogenomics
$2,867,651University Of California San Diego · U01 · FY2002 · HL
Novel antibacterial agents for treatment of Tularemia
$2,864,024Affinium Pharmaceuticals, Inc. · U01 · FY2003 · AI
Covalent targeting strategies
$2,861,620John Damon Chodera · Sloan-Kettering Inst Can Research · U19 · FY2022 · AI
Genomics of Acute Myelogenous Leukemia
$2,861,276Timothy J Ley · Washington University · P01 · FY2015 · CA
Virology Core
$2,859,841Xuping Xie · University Of Texas Med Br Galveston · U19 · FY2023 · AI
Drug Repurposing Screening for Rare and Neglected Diseases
$2,859,284Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Lupus Clinical Trials
$2,858,919Sarfaraz Hasni · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
FLOURESCENT PROBES & IMAGING FOR NETWORKS & PATHWAYS
$2,852,937Alan S Waggoner · Carnegie-Mellon University · U54 · FY2009 · RR
Flourescent Probes & Imaging - Networks & Pathways(RMI)
$2,852,937Alan S Waggoner · Carnegie-Mellon University · U54 · FY2009 · RR
San Diego Center for Systems Biology: From Maps to Models
$2,849,208Jeff M Hasty · University Of California, San Diego · P50 · FY2015 · GM
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH
$2,848,504Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2009 · RR
Chemical Countermeasures Collaboration: Chemical Threats Affecting the Respiratory/Pulmonary System
$2,847,929Office Of The Director, National Institutes Of Health · Y01 · FY2025 · OD
Targeting Cellular Senescence to Extend Healthspan
$2,846,464Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2020 · AG